Dynavax Technologies Corp.
(NASDAQ : DVAX)

( )
DVAX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.41%202.721.3%$426.59m
BIIBBiogen Inc.
-2.46%220.061.3%$391.11m
GILDGilead Sciences, Inc.
-0.49%64.910.9%$378.65m
CELGCelgene Corporation
1.13%102.951.3%$367.47m
ILMNIllumina, Inc.
-0.36%309.443.5%$247.45m
REGNRegeneron Pharmaceuticals, Inc.
-0.46%300.192.6%$218.58m
EXASExact Sciences Corporation
-0.95%96.4724.1%$199.33m
VRTXVertex Pharmaceuticals Incorporated
-0.84%176.231.9%$176.44m
ALXNAlexion Pharmaceuticals, Inc.
-1.58%98.412.0%$169.95m
AAgilent Technologies, Inc.
-0.44%74.591.6%$143.57m
SRPTSarepta Therapeutics, Inc.
-1.91%85.7714.6%$132.47m
BMRNBioMarin Pharmaceutical Inc.
1.84%69.154.3%$96.30m
SGENSeattle Genetics, Inc.
1.70%87.406.2%$95.18m
NKTRNektar Therapeutics
-2.81%17.275.5%$84.77m
ALDRAlder Biopharmaceuticals, Inc.
0.11%18.9210.2%$81.63m

Company Profile

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.